Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma

Gemcitabine resistance is currently the main problem of chemotherapy for advanced pancreatic cancer patients. The resistance is thought to be caused by altered drug metabolism or reduced apoptosis of cancer cells. However, the underlying mechanism of Gemcitabine resistance in pancreatic cancer remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Feng, Huang, Mei, Meng, Futao, Huang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996282/
https://www.ncbi.nlm.nih.gov/pubmed/29922161
http://dx.doi.org/10.3389/fphar.2018.00584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996282/
https://www.ncbi.nlm.nih.gov/pubmed/29922161
http://dx.doi.org/10.3389/fphar.2018.00584

Ejemplares similares